HYBRID AMIDES BASED ON TRIAZOLE AND THIAZOLIDINE HAVING ANTIMICROBIAL ACTIVITY Russian patent published in 2019 - IPC C07D417/12 C07D417/14 A61K31/427 A61P31/10 

FIELD: medicine.

SUBSTANCE: invention relates to compounds of general formula (I) or a pharmaceutically acceptable salt thereof, where Z is independently selected and represents a fragment whose structural formula is given below, wherein the asterisk indicates an attachment point; X is independently selected and represents O or S; R¹ is independently selected and represents a benzylidene moiety optionally containing 1–3 substituents R', which is independently selected and represent -C_1-7-alkyl, -OC_1-7-alkyl, halogen, -OH, -C_5-7-cycloalkyl, -piperazinyl, optionally containing a substitute selected from -C_1-7-alkyl; wherein the asterisk indicates the substitution attachment point; R² is independently selected and represents H, -C_1-7-alkyl, phenyl; said phenyl in fragment R² is optionally substituted with at least two substitutes, which are halogen; R³ is independently selected and represents halogen; R⁴ is independently selected and represents halogen; n take values from 0 to 3.

Z: , , , , , ;

R¹: .

EFFECT: disclosed compounds are intended for treating and/or preventing an infectious disease of microbial aetiology in a subject caused by a fungal infection, wherein the disease of the microbial aetiology is caused by fungi of the genus Candida speciales, Aspergillus speciales, Microsporum speciales, Trichophyton speciales and/or Epidermophyton speciales.

13 cl, 5 tbl, 56 ex